De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
MicroPort CardioFlow Medtech Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Jeffrey R Lindstrom
Algemeen directeur
CN¥4.0m
Totale compensatie
| Percentage CEO-salaris | 59.8% |
| Dienstverband CEO | 1.2yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 4yrs |
| Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
MicroPort CardioFlow Medtech Corporation (HKG:2160) Stocks Shoot Up 34% But Its P/S Still Looks Reasonable
Sep 27
After Leaping 34% MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares Are Not Flying Under The Radar
Sep 27Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥349m |
| Mar 31 2024 | n/a | n/a | -CN¥410m |
| Dec 31 2023 | CN¥4m | CN¥2m | -CN¥472m |
Compensatie versus markt: De totale vergoeding ($USD 570.48K ) Jeffrey R } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 354.63K ).
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Jeffrey R te vergelijken met de prestaties van het bedrijf.
CEO
Jeffrey R Lindstrom (57 yo)
1.2yrs
Tenure
CN¥4,004,000
Compensatie
Mr. Jeffrey R Lindstrom is President, Executive Director & General Manager of MicroPort CardioFlow Medtech Corporation from August 29, 2023. He served as senior director of engineering in Edwards Lifescien...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 1.2yrs | CN¥4.00m | geen gegevens | |
| Executive Director & First VP of Total Solutions | 2.4yrs | CN¥3.91m | 0.058% CN¥ 1.2m | |
| VP & Executive Director | 4.1yrs | CN¥2.70m | 0.042% CN¥ 830.1k | |
| Joint Company Secretary | 4yrs | geen gegevens | geen gegevens | |
| Joint Company Secretary | 4yrs | geen gegevens | geen gegevens |
4.0yrs
Gemiddelde duur
43yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 2160 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 1.2yrs | CN¥4.00m | geen gegevens | |
| Executive Director & First VP of Total Solutions | 2.4yrs | CN¥3.91m | 0.058% CN¥ 1.2m | |
| VP & Executive Director | 4.1yrs | CN¥2.70m | 0.042% CN¥ 830.1k | |
| Independent Non-Executive Director | 3.8yrs | CN¥254.00k | geen gegevens | |
| Non-Executive Director | 5.2yrs | geen gegevens | geen gegevens | |
| Non-Executive Chairman of the Board | 4.1yrs | CN¥3.16m | 0.031% CN¥ 609.1k | |
| Non-Executive Director | 5.2yrs | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 3.8yrs | CN¥254.00k | geen gegevens | |
| Independent Non-Executive Director | 3.2yrs | CN¥254.00k | 0.0012% CN¥ 24.5k |
3.8yrs
Gemiddelde duur
47yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 2160 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).